Track topics on Twitter Track topics that are important to you
Biovista will collaborate with Hewlett Packard Enterprise (HPE) to advance Biovista's Project Prodigy Big Data AI healthcare platform applied in the personalized medicine vertical. Advances from the HPE-Biovista collaboration will be used initially within the context of Biovista's existing collaboration with Sarah Bush Lincoln Health Center (SBL), a hospital and health care organization that is home to more than 300,000 provider office visits per year.
HPE is joining the ongoing effort between Biovista and SBL and will work with Biovista to help advance the capabilities and productization of Project Prodigy as a Big Data AI engine in the personalized medicine vertical as a start.
Biovista develops advanced technologies that use Big Data and next generation analytics to address major needs in data-heavy verticals, with healthcare and personalized medicine as an initial focus. HPE and Biovista's new collaboration will leverage HPE computing and Biovista's Big Data AI engine, Project Prodigy, to identify and validate new therapeutic options for personalized medicine, starting with the community hospital setting.
"It's exciting to see Project Prodigy help advance the practice of healthcare," Aris Persidis, Ph.D. Biovista's president said. "The aim is to help doctors deliver more targeted care with fewer side effects in a way that integrates well with their workflow and is also cost effective. We are happy to be working with HPE within the context of our work at SBL to accelerate the advances of Project Prodigy in personalized medicine."
"Medicine as currently practiced in the United States is hardly sustainable financially," noted James Hildebrandt, MD, VP Medical Affairs at SBL. "We need to deliver better care with fewer side effects at a lower cost, or the system will fail. Efforts like the SBL-Biovista-HPE collaboration in personalized medicine that aim to combine IT efficiencies with sound medical practice promise to move us in the right direction."
"Project Prodigy offers unique prospects to apply AI Deep Learning techniques and Big Data analytics to personalized medicine," said Dr. Stephen Wheat, Director, HPC Vertical Solutions and Apollo Pursuits. "Combining HPE capabilities with Project Prodigy is a powerful and exciting path forward for us in personalized medicine, as well as in other verticals that have emerging AI Deep Learning workflows."
James Hildebrandt further noted, "We are very happy to work with Biovista to advance the practice of personalized medicine using the very best technologies available. SBL continually works to incorporate leading edge capabilities, including those at the forefront of big data healthcare analytics, such as Biovista's Project Prodigy, as we deliver high quality care close to home for our patients and communities. We see the Biovista-HPE link within the context of our SBL-Biovista collaboration as very positive for SBL and our patient community."
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...